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Background/Purpose: Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous con-
nective tissue disorder characterized by hyperextensibility of the skin, hypermobility of joints, and tissue
fragility. This retrospective study analyzed the characteristics of patients with EDS.
Methods: Review of medical records identified 16 cases of EDS during the study period from November
1997 to October 2002. Data on these patients, including clinical presentation, physical examinations,
Beighton score, echocardiogram, bone mineral density findings and clinical classification, were analyzed.
Results: The age of the patients ranged from 13 months to 36 years. All patients had skin hyperextensibi-
lity, joint hypermobility (Beighton score > 5 points), and tissue fragility. Complete bone mineral density
study was performed in 11 patients and revealed that all had osteoporosis. Echocardiographic study
was performed in 14 patients and showed aortic root dilatation/valve prolapse in 6/14 (43%). Other common
features of EDS had the following prevalence: premature rupture of membranes in 3/16 (19%); prematurity
in 3/16 (19%); neonatal hypotonia in 5/16 (31%); congenital hip dislocation in 3/16 (19%); unstable gait
in 7/16 (44%); bone fracture(s) in 3/16 (19%); motor delay in 3/16 (19%); scoliosis in 3/16 (19%); short
stature in 7/16 (44%); and positive family history in 8/16 (50%). All patients had a Beighton score of more
than 5 points.
Conclusion: The results of this study emphasize the importance of echocardiographic monitoring of aortic
size and valvular condition, and assessment of bone mineral density in patients with EDS. Clinical evaluation
and counseling should be undertaken prior to pregnancy in patients with EDS because of the risk from labor
and vaginal delivery in patients with type IV and the inability to distinguish EDS subtypes in Taiwan due to
the unavailability of biochemical assay or molecular mutation analysis as part of standard care. [ J Formos
Med Assoc 2006;105(6):475–480]
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The first comprehensive description of a syndrome
comprising laxity and fragility of the skin associat-
ed with hypermobility of the large joints was pub-
lished in 1892 by Tschernogobow in Moscow.1 The
eponym of Ehlers-Danlos syndrome (EDS) was first
suggested by Poumeau-Delille and Soulie.2 It cur-
rently describes a group of connective tissue dis-
orders distinguished not only by the triad of skin
hyperextensibility, joint hypermobility and tissue
*Correspondence to: Dr. Shuan-Pei Lin, Department of Pediatrics, Mackay Memorial Hospital, 92, Section 2,
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fragility, but also by its heterogeneity on clinical,
genetic, and biochemical grounds.3
In 1988, Beighton et al published an interna-
tional nosology of connective tissue disease where
nine subcategories of EDS were defined.4 Subse-
quently, they correlated the subtypes with various
biochemical and molecular abnormalities and also
published an equivalent molecular nosology,5 both
of which were revised in 1998.6 Most cases are types
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data. Bone mineral density of total body (BMDTB,
g/cm2) was determined by dual energy X-ray ab-
sorptiometry (DXA). Due to the lack of available
reference data for BMD with DXA in Taiwanese
children, normative reference data obtained from
the literature9–11 were used in this study. These BMD
results were converted to age-specific T-scores. Ac-
cording to the classification used by our radiolo-
gists, osteopenia was defined as a T-score less than
one standard deviation below the mean (< –1 SD)
and osteoporosis as a T-score < –2 SD.
Hypermobility was assessed using the scale
derived by Beighton as follows: (1) passive dorsi-
flexion of the little fingers beyond 90° , one point
for each hand; (2) passive apposition of the thumbs
to the flexor aspect of the forearm, one point for
each hand; (3) hyperextension of the elbows be-
yond 10° , one point for each elbow; (4) hyper-
extension of the knees beyond 10° , one point
for each knee; and (5) forward flexion of the
trunk with knees fully extended and the palms of
the hands being able to rest flat on the floor, one
point.12 Joint hypermobility was defined as a score
of 5/9 or greater.
Results
Table 1 lists the findings of physical examination,
Beighton score evaluation, BMDTB data, echocar-
diogram and clinical classification of the patients.
The clinical characteristics, complications and im-
aging findings are summarized in Table 2. There
were nine male and seven female patients with age
ranging from 1 year 6 months to 36 years (mean,
11.3 years). All patients presented with skin hy-
perextensibility and joint hypermobility (Figures
1 and 2), all with Beighton score above 5 points
(range, 6–9), and tissue fragility with ecchymosis
or easy bruising. Features associated with EDS
had the following prevalence: premature rupture
of membranes (PROM) in three (19%) patients,
prematurity in three (19%), neonatal hypotonia
in five (31%), congenital hip dislocation in three
(19%), unstable gait in seven (44%), bone frac-
ture(s) in three (19%), motor developmental de-
I (gravis type), II (mitis type) or III (hypermobile
type), which consist of approximately 30% each;
approximately 10% of cases are type IV (ecchy-
motic type), and the remaining subtypes are rare.7
EDS is currently classified into 10 clinical forms.8
Heterogeneity among these clinical forms both
complicates the diagnosis of EDS and makes ac-
curate diagnosis imperative. Identification of the
syndrome is paramount because of its potentially
life-threatening associations and unique require-
ments for management.
The prevalence of all forms of EDS was previ-
ously estimated at 1:150,000, but recent reports
suggest a higher prevalence of 1:5000.6,7 This in-
crease in prevalence may be because the disorder
has become easier to diagnose, and more sub-
types are being identified. EDS affects all races and
ethnic groups without sex predominance.6 A thor-
ough knowledge of the pregnancy, musculoske-
letal, cardiovascular, gastrointestinal and derma-
tologic manifestations of EDS and their manage-
ment is mandatory to prevent unnecessary mor-
bidity and mortality. Although EDS has been
widely reported in the medical literature, there is
a relative lack of reports in the Taiwanese litera-
ture. This retrospective study analyzed the charac-
teristics of patients with the clinical presentation
of EDS in two medical centers in Taiwan.
Methods
This retrospective study analyzed the clinical char-
acteristics of patients with EDS treated between
November 1997 and October 2002 at the Depart-
ment of Pediatrics of both Mackay Memorial Hos-
pital and Taipei Veterans General Hospital. Sixteen
patients with clinical features of EDS treated dur-
ing this period were included. Most of the patients
were seen in genetics clinics, some were referred
by orthopedists and neurologists, or from local
hospitals.
The data analyzed included family history,
birth history, clinical presentation, findings of
physical examinations with Beighton score evalu-
ation, results of echocardiography and follow-up
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lay in three (19%), scoliosis in three (19%), short
stature (body height, < –2 SD) in seven (44%),
and positive family history in eight (50%). Com-
plete BMDTB study was performed in 11 patients
and all had underlying osteoporotic problems (T-
score, < –2 SD). There were also 14 patients who
received echocardiogram examination, of whom
six (43%) had mild aortic root dilatation/valve
prolapse. The 36-year-old female patient died of
uterine rupture in the 37th gestational week of
her second pregnancy in spite of her physician’s
strong suggestion of earlier cesarean section.
Discussion
The diagnosis of EDS is mainly based on clinical
presentation, family pedigree analysis, and, if
possible, is confirmed by demonstration of speci-
fic biochemical or genetic defects. Recognition of
the disease on clinical grounds can be difficult
because skin elasticity and joint mobility are grad-
ed and subjective traits. Physical examination,
however, remains the initial step in the diagno-
sis of EDS. All of the 16 patients included in this
study had clinical characteristics of EDS. Joint mo-
bility may be quantified by the Beighton score.
Pedigree analysis may be helpful to classify pa-
tients who are thought to have EDS because in-
heritance patterns differ among subtypes.13 Half
of the patients in this study had a positive family
history, although the phenotypes were highly vari-
able individually. Growth or feeding problems in
EDS are rare and none was detected in this series.
Developmental and behavioral problems, how-
ever, are more frequently observed and motor de-
lay can sometimes be seen in patients with inabil-
ity to stabilize the joints due to EDS. Motor delay
problems requiring early intervention with reha-
bilitation were found in nearly one fifth (19%) of
our patients. Standard pediatric developmental as-
sessment is required for evaluation of motor delay
in patients with EDS.
Complications of pregnancy and delivery are
related to the subtype of EDS involved, and it is
recommended that all pregnant patients with
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EDS be referred to a high-risk obstetric practice,
neonatologist and geneticist in a medical center.
The risk of severe uterine hemorrhage and/or rup-
ture is a hallmark of type IV EDS, and the risk of
severe hemorrhagic complications from labor and
vaginal delivery, including death or shock, remain
unacceptably high, in the range of 10% per preg-
nancy.14,15 No published standards of care exist for
delivery in affected women; however, pregnant in-
dividuals with EDS type IV should be delivered by
cesarean section with special anesthetic considera-
tions16,17 and not allowed to enter into labor. For
other EDS subtypes, vaginal delivery is possible.
Counseling with regard to the risks involved, and
clinical evaluation, should be undertaken prior
to pregnancy in all patients with EDS, since the
subtypes are not distinguished in Taiwan due to
the lack of availability of biochemical assay or mo-
lecular mutation analysis as part of standard care.
High rates of miscarriage and premature deliveries
due to cervical incompetence may compromise the
fetus in women with EDS.18,19 The amniotic mem-
branes are of fetal origin, and if EDS affects the
fetus, PROM commonly occurs. Affected infants
might exhibit changes in vascular resistance and
subsequently reduced blood flow. This might ex-
plain the higher rates of fetal growth retardation
in pregnancies with EDS. These features were
observed in this series with prematurity in 19%,
PROM in 19%, and short stature in 44%.
There have been numerous reports of cardiac
and aortic abnormalities in EDS, including mitral
valve prolapse, aortic dilatation, and aortic dis-
section/rupture.20–22 Cardiovascular abnormalities
were found in 43% of our patients who received
echocardiographic examination. This finding sug-
gests that echocardiographic evaluation of aortic
size should be included in the initial evaluation of
new patients with EDS, as in patients with Marfan
syndrome.23 For patients with normal echocardio-
grams at the initial exam, repeated echocardio-
grams at 3-year intervals may be sufficient. Patients
with normal initial echocardiograms who are in-
volved in competitive athletics (junior high school
and beyond) should be evaluated more frequently.
Patients with aortic diameters greater than +2 SD
for body surface area24 should be followed yearly,
or occasionally at 6-month intervals, depending on
the apparent rate of increase.
Hypermobility of the joints is a cardinal fea-
ture of EDS and joint dislocations are a relatively
frequent complication of any form. Congenital
dislocation of the hip is present in about 5% of
affected neonates,25 and its prevalence in this se-
ries of patients was 19%. Some reports indicated
that most patients have radiologically detectable
osteopenia/osteoporosis, but pathologic frac-
Table 2. Clinical presentations, imaging study findings and
features in 16 patients with Ehlers-Danlos syndrome
n (%)
Clinical presentations of triad
Skin hyperextensibility 16 (100)
Joint hypermobility (Beighton score > 5 points) 16 (100)
Tissue fragility with ecchymosis or easy bruising 16 (100)
Imaging study
Osteopenia/osteoporosis 11/11 (100)
Aortic dilatation/valve prolapse 6/14 (43)
Features
Positive family history 8 (50)
Unstable gait 7 (44)
Short stature (body height < –2 SD) 7 (44)
Neonatal hypotonia 5 (31)
Premature rupture of membranes 3 (19)
Premature birth 3 (19)
Congenital hip dislocation 3 (19)
Frequent bone fracture(s) 3 (19)
Motor developmental delay 3 (19)
Scoliosis 3 (19)
Figure 1. Stretchability of ears in a boy with Ehlers-Danlos syndrome.
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tures are rare. Similar findings were also made in
this study, including osteoporosis among all ex-
amined patients, and a relatively high prevalence
of bone fracture episodes of 19%. Muscular hy-
potonicity may be an initial feature in early child-
hood; thus, EDS should be included in the differ-
ential diagnosis of the “floppy infant”.26 In this
series, 44% of patients had an initial diagnosis of
neonatal hypotonia.
In conclusion, the results of this study high-
light the importance of echocardiographic eva-
luation of aortic size and valvular condition, and
bone mineral density in patients with EDS, and
regular follow-up monitoring for this condition.
Clinical presentation provides insufficient in-
formation for the definite diagnosis of EDS, and
EDS type IV is associated with an increased risk
of death. Unfortunately, there are other diseases,
especially collagen fiber disorders, which share
many of the clinical features of EDS. A thorough
knowledge of the systemic manifestations of
EDS, its involvement in multiple organ systems,
and its management are mandatory to prevent
morbidity and mortality. The availability of bio-
chemical assay or molecular mutation analysis as
part of standard practice to help clinicians in Tai-
wan to make a more accurate diagnosis of EDS,
other than clinical phenotype, is needed.
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